Axelar AB
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With A Solid Tumors, Hematological Malignancies | Phase 1 | 2012-10-01 |
| Completed | Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung Non-small-cell Lung Cancer, Squamous Cell Carcinoma, Adenocarcinoma of the Lung | Phase 2 | 2011-12-01 |
| Completed | A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small Non Small Cell Lung Cancer | Phase 1 | 2011-01-01 |
| Completed | A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer Solid Tumors | Phase 1 | 2008-04-01 |